CLOV vs SOLS · rev $1.37B vs P/E 71, rev $969.0M
Clover Health Investments Corp (CLOV) versus Solstice Advanced Materials, Inc (SOLS) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Solstice Advanced Materials, Inc (SOLS) is a specialty chemicals company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported SOLS revenue for 2025-09-30 was $969.0M. Net income was -$9.0M. Revenue was up 6.8% from 2024-09-30 to 2025-09-30. SOLS currently screens at market cap $13.51B and trailing P/E 71.5.
CLOV currently screens at market cap $1.55B. SOLS currently screens at market cap $13.51B and trailing P/E 71.5.
Not investment advice. Open the CLOV and SOLS stock pages for the full models.
Not investment advice.